Hakeem Health Raises $1.65M for AI Clinical Decision Support

Saudi Arabia's healthtech innovator, Hakeem Health, has successfully closed a $1.65 million funding round, signaling strong investor confidence in its AI-driven clinical decision support platform. The investment was spearheaded by prominent Saudi venture capital firm Merak Capital, with additional backing from Sanabil 500. This infusion of capital is earmarked to accelerate the adoption of Hakeem Health's core offering, HakeemDx, across the Gulf Cooperation Council (GCC) region.

Founded in 2022 by Bilal Adi and Mohammed Ayyad, Hakeem Health operates on a Software-as-a-Service (SaaS) model. Its flagship product, HakeemDx, is designed to integrate seamlessly with existing hospital information systems, including Electronic Medical Records (EMRs) and laboratory platforms. The system provides clinicians with real-time, evidence-based guidance directly at the point of care, available in both Arabic and English. This capability aims to significantly reduce medical errors and enhance patient outcomes, a critical need in a region prioritizing healthcare quality improvements.

The strategic importance of HakeemDx lies in its ability to augment physician capabilities by delivering timely, accurate clinical insights. In a healthcare environment increasingly strained by complex cases and the need for rapid diagnosis, tools that support faster, more informed decision-making are becoming indispensable. The GCC healthcare market, valued in the tens of billions of dollars and experiencing consistent growth driven by government initiatives and an aging population, presents a substantial opportunity for such technological advancements.

Merak Capital, a Saudi-based investment firm regulated by the Capital Market Authority, highlighted its strategic alignment with this investment. The firm focuses on high-growth technology companies, particularly those leveraging artificial intelligence to drive innovation. This funding round also resonates with Saudi Arabia's Vision 2030 objectives, supporting the nation's push towards digital transformation and the development of a robust knowledge-based economy. Abdulelah Alshareef, Principal of Venture Capital at Merak Capital, commented on the investment, stating, "AI is already delivering measurable productivity gains across industries, and healthcare remains a critical area for impact. Hakeem addresses key challenges in clinical decision-making by enabling faster, more accurate assessments that can improve patient outcomes."

Hakeem Health's SaaS model is built for scalability, targeting institutional clients including hospitals, universities, and healthcare payers. The company's expansion plans are ambitious, aiming to embed HakeemDx within the workflows of over 2,000 hospitals across key regional markets like Saudi Arabia, the UAE, and Egypt. This focus on recurring revenue contracts positions the company for sustained growth within a sector actively seeking efficiency gains and improved patient care standards.

Bilal Adi, co-founder and CEO of Hakeem Health, expressed enthusiasm for the partnership, noting, "Our mission is to help clinicians make better decisions, faster, so patients receive better care. Merak Capital’s investment reinforces that mission and supports the next phase of our growth." The company's trajectory aligns with a broader trend in the Middle East where digital health solutions are gaining significant traction, driven by both public sector investment and private sector innovation. Comparable deals in the healthtech space within the region have seen substantial investor interest, underscoring the market's potential.